BSE filing, NSE: IDFCFIRSTB. Summary written from the filing by ALFA Finder's alert engine.
IDFC First Bank Ltd: key numbers
- Share price
- ₹73.53
- Market cap
- ₹63,418 Cr
- Revenue (annual)
- ₹40,549 Cr
- Net profit (annual)
- ₹1,611 Cr
- P/E (TTM)
- 21.1×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 36.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IDFC First Bank Ltd
All →IDFC First Bank Earnings Call Transcript: Key Takeaways
IDFC First Bank reports its second consecutive quarter of PAT over ₹1,000 Cr, heavily impacted by massive FCNR mobilization which technicality suppressed NIMs while providing long-term structural liquidity.
IDFC First Bank Management Change
IDFC First Bank's board approved reappointing Pradeep Natarajan as Whole-Time Director for three years from June 2027, and appointing S. Ganesh Kumar as Part-Time Chairperson from May 2027. Independent director Aashish Kamat ceases December 17, 2026 on tenure completion.
IDFC First Bank Investor Presentation: Key Takeaways
Q2 FY27 PAT Rs 1,045 Cr (+196.5% YoY), core PAT Rs 1,036 Cr; NII Rs 6,184 Cr (+21%); GNPA 1.32%; FCNR(B) mobilisation Rs 34,390 Cr drives deposits.
IDFC First Bank Other Announcement
IDFC First Bank filed a NIL security cover certificate for the quarter ended 30 September 2026. It has only unsecured debt, so no cover ratio applies.
IDFC First Bank Results Update
IDFC First Bank's press release reports Q2 FY27 profit growth, with deposits up strongly year-on-year. It also highlights FCNR(B) mobilisation and a debut S&P investment-grade rating.
IDFC First Bank Q2 FY27 Results: Net Profit ₹1,049 Cr, Up 201.7% YoY
IDFC First Bank Ltd reported revenue from operations of ₹11,923 Cr (+20.0% YoY) and net profit of ₹1,049 Cr (+201.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,049 Cr · +201.7% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.